Mitsubishi UFJ Asset Management Co. Ltd. Makes New $264.01 Million Investment in Danaher Corporation $DHR

Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 366,661 shares of the conglomerate’s stock, valued at approximately $264,011,000. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.05% of Danaher at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the stock. Main Street Group LTD acquired a new position in shares of Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher in the 2nd quarter worth approximately $25,000. JPL Wealth Management LLC bought a new stake in Danaher during the third quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new stake in Danaher during the fourth quarter worth approximately $26,000. Finally, WFA of San Diego LLC acquired a new position in Danaher during the second quarter valued at approximately $26,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.0%

DHR opened at $202.44 on Tuesday. The business has a 50 day moving average of $193.52 and a 200-day moving average of $192.67. The stock has a market capitalization of $142.31 billion, a price-to-earnings ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the previous year, the firm posted $0.77 earnings per share. Danaher’s revenue was up 5.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. HSBC dropped their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Morgan Stanley lowered their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. JPMorgan Chase & Co. cut their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Finally, UBS Group decreased their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

View Our Latest Stock Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.